Research Digest — 2026-10-19

Week of 2026-10-19. Automatically gathered headlines; always read the original source. Animal or small studies are early findings and may not apply to people. Not medical advice.

Scientists may have overlooked a hidden Alzheimer's culprit for decades
Source: ScienceDaily – Alzheimer's
For decades, scientists have focused on amyloid beta as a major culprit behind Alzheimer’s disease, spending billions of dollars developing treatments that have often delivered disappointing results. Now, researchers at UC Santa Cruz are drawing attention to a largely overlooked peptide called P3 that could also play a role in the disease. Previously believed to be harmless, P3 can form harmful-lo
Scientists reverse Alzheimer’s in mice with breakthrough nanotechnology Preliminary / early-stage research
Source: ScienceDaily – Alzheimer's (health)
A new nanotechnology treatment reversed Alzheimer’s symptoms in mice by restoring the brain’s natural cleanup system. The specially engineered nanoparticles helped clear toxic amyloid proteins from the brain and repair the blood-brain barrier, which normally protects and regulates the brain’s environment. In one striking experiment, elderly mice treated with the therapy later behaved like healthy
Scientists find hidden driver of aging and a simple amino acid that fights memory loss in mice Preliminary / early-stage research
Source: ScienceDaily – Memory
Scientists discovered that declining levels of a protein called Menin may help drive aging, and restoring it in older mice reversed several age-related changes in just 30 days. Even more surprisingly, supplementing with a simple amino acid called D-serine improved memory and learning, offering a potential new approach to age-related cognitive decline.
Brain PET scans help select and monitor patients for new Alzheimer's drugs
Source: Medical Xpress – Dementia
Nuclear medicine is playing an increasingly important role in the diagnosis and treatment of Alzheimer's disease, helping clinicians visualize the biological changes associated with the condition and guide decisions about new therapies. Amyloid PET imaging is being used to confirm the presence of amyloid pathology and support treatment decisions for patients receiving anti-amyloid drugs, while tau
PMOS/PCOS may be linked to Alzheimer's disease and dementia - Endocrine Society
Source: Google News – Alzheimer research
PMOS/PCOS may be linked to Alzheimer's disease and dementia Endocrine Society
Rare study reveals a striking divide inside an Alzheimer’s patient’s brain
Source: ScienceDaily – Alzheimer's
A rare examination of an Alzheimer’s patient’s brain revealed that regions cleared of amyloid plaques had remarkably little of the harmful tau buildup associated with memory loss, while neighboring areas showed extensive damage. The discovery suggests that removing amyloid may have lasting protective effects and could help slow Alzheimer’s progression, especially when treatment begins early.
Discovery of 'item memory' brain cells offers new Alzheimer's treatment target
Source: ScienceDaily – Memory
Researchers have discovered the neurons responsible for 'item memory,' deepening our understanding of how the brain stores and retrieves the details of 'what' happened and offering a new target for treating Alzheimer's disease.
Napping linked to dementia risk
Source: Medical Xpress – Dementia
Your napping habits might be a warning flag for dementia, a new study says.
Dementia research priorities in Latin America and the Caribbean: findings from a multi-country stakeholder survey - Nature
Source: Google News – Alzheimer research
Dementia research priorities in Latin America and the Caribbean: findings from a multi-country stakeholder survey Nature
The hidden math of Alzheimer's could point to new treatments
Source: ScienceDaily – Alzheimer's
Mathematics may hold unexpected clues to understanding Alzheimer’s disease. Scientists have developed a model showing how common metals like copper and zinc may influence the buildup of proteins associated with the disease, while also exploring possible ways to stop the process. The findings could help researchers identify promising strategies for preventing harmful plaque formation.
New drug-delivery method offers promise in fight against neurodegenerative diseases
Source: Medical Xpress – Dementia
For patients battling neurodegenerative diseases like ALS, Parkinson's, Alzheimer's and other dementias, delivering disease-fighting antibody drugs directly to the brain has proven to be a difficult task. Our bodies set up tight walls to prevent infections from spreading to the brain, where they often become fatal.
Frequent, Unintended Napping Tied to Higher Dementia Risk - Johns Hopkins Bloomberg School of Public Health
Source: Google News – Alzheimer research
Frequent, Unintended Napping Tied to Higher Dementia Risk Johns Hopkins Bloomberg School of Public Health
Alzheimer’s risk gene APOE4 may have a reversible weakness
Source: ScienceDaily – Alzheimer's
The Alzheimer’s risk gene APOE4 may actively damage brain blood vessels and sabotage the cellular systems that remove harmful proteins. Researchers were able to reverse some of these effects in experiments, revealing promising new targets for Alzheimer’s, Parkinson’s, and other neurodegenerative diseases.
Who gets Alzheimer's drugs? Race, vulnerability and health status shape access
Source: Medical Xpress – Dementia
The first disease-modifying drugs for Alzheimer's disease offer patients the ability to slow cognitive decline by targeting amyloid plaques in the brain. But a new study suggests that not all patients have the same opportunity to receive these treatments.
BU Alzheimer’s Disease Research Center Receives $24 Million in Fresh Funding - Boston University
Source: Google News – Alzheimer research
BU Alzheimer’s Disease Research Center Receives $24 Million in Fresh Funding Boston University
Glucosamine, a popular joint supplement, linked to faster Alzheimer’s progression
Source: ScienceDaily – Alzheimer's
A large health-record analysis found that glucosamine use was associated with a 25% higher likelihood of mild cognitive impairment progressing to dementia. Lab experiments suggest the popular joint supplement may intensify an abnormal sugar-tagging process in the Alzheimer’s brain, although researchers say clinical trials are needed to determine whether it actually causes harm.
MRI analysis tool reveals brain artery differences missed by older software
Source: Medical Xpress – Dementia
The brain's network of blood vessels plays a critical role in maintaining neurological health. Changes to these vessels are associated with conditions including stroke, cognitive impairment and dementia. Yet studying the brain's smallest arteries can be challenging, in part because extracting detailed measurements from MRI images often requires substantial manual work.
Duke launches national hub to advance trustworthy AI for aging and dementia care - Duke School of Medicine
Source: Google News – Alzheimer research
Duke launches national hub to advance trustworthy AI for aging and dementia care Duke School of Medicine
Scientists find a new layer of Alzheimer’s hidden in the genome
Source: ScienceDaily – Alzheimer's
Scientists found that the 3D organization of DNA is disrupted in several types of brain cells affected by Alzheimer’s disease, altering how important genes are switched on and off. The discovery reveals a previously underexplored layer of the disease that could open new paths for understanding and eventually treating Alzheimer’s.
Epilepsy associated with increased risk of dementia before age 65
Source: Medical Xpress – Dementia
People with epilepsy may be more likely to develop young-onset dementia than people without epilepsy, according to a study published in Neurology. Young-onset dementia, sometimes called early-onset dementia, develops before age 65. The study does not prove that epilepsy is a direct cause of young-onset dementia; it only shows an association.
Arrowhead’s Alzheimer’s disease drug reduces tau in Phase I/IIa trial - Clinical Trials Arena
Source: Google News – Alzheimer research
Arrowhead’s Alzheimer’s disease drug reduces tau in Phase I/IIa trial Clinical Trials Arena
Early statin use linked to 15% lower dementia risk
Source: ScienceDaily – Alzheimer's
Starting statins soon after a type 2 diabetes diagnosis may do more than protect the heart. In a nationwide Danish study of more than 132,000 people, those who began statin treatment within a year of diagnosis had a 15% lower relative risk of developing dementia over 10 years compared with those who did not start statins.
Molecular glue degraders show early promise in reducing Alzheimer's-linked brain plaques
Source: Medical Xpress – Dementia
A research team led by Indiana University School of Medicine scientists has discovered a new method for reducing the formation of amyloid plaques, which disrupt brain function in all aging adults but are particularly prevalent in patients with Alzheimer's disease and related dementias.
Will We Ever Understand Dementia? - The New York Times
Source: Google News – Alzheimer research
Will We Ever Understand Dementia? The New York Times
Alzheimer’s may leave a mark on the brain long before plaques appear
Source: ScienceDaily – Alzheimer's
Brain changes associated with Alzheimer’s may begin at least seven years before amyloid plaques become detectable with current PET scans. Researchers uncovered the signal by tracking healthy older adults with repeated brain imaging over nearly 20 years. The discovery could help scientists identify Alzheimer’s earlier and suggests that important disease processes may start before visible plaque bui